Abstract #1406

Comparison of Capability for Therapeutic Outcome Prediction among CEST, DWI and PET/CT in Non-Small Cell Lung Cancer Conservative Therapy

Yoshiharu Ohno^1,2, Masao Yui³, Kaori Yamamoto³, Takeshi Yoshikawa^1,4, Daisuke Takenaka^1,4, Masato Ikedo³, Akiyoshi Iwase⁵, Yuka Oshima⁶, Nayu Hamabuchi⁶, Satomu Hanamatsu⁶, Hiroyuki Nagata², Takahiro Ueda¹, Hirotaka Ikeda¹, Yoshiyuki Ozawa¹, and Hiroshi Toyama¹

¹Radiology, Fujita Health University School of Medicine, Toyoake, Japan, ²Joint Research Laboratory of Advanced Medical Imaging, Fujita Health University School of Medicine, Toyoake, Japan, ³Canon Medical Systems Corporation, Otawara, Japan, ⁴Diagnostic Radiology, Hyogo Cancer Center, Akashi, Japan, ⁵Fujita Health University Hospital, Toyoake, Japan, ⁶Fujita Health University School of Medicine, Toyoake, Japan

Synopsis

Keywords: Lung, Cancer, CESTWe hypothesize that CEST imaging has a potential for therapeutic outcome prediction in NSCLC patients treated with chemoradiotherapy and may play as one of the predictors in this setting. The purpose of this study was to compare the capability for therapeutic outcome prediction among CEST imaging, DWI and FDG-PET/CT in NSCLC patients with conservative therapy.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.